Good Health At Low Cost 25 Years On

In this book, an international team of authors have sought to understand how five countries have made progress towards the ultimate goal of Good health at low cost in recent decades (and what happened to others that were viewed as successes 25 years ago). They take a holistic approach, demonstrating the strengths of collaboration across disciplines and continents. In doing so, they provide important lessons for other countries seeking to emulate success.

The United States has been a generous sponsor of global health programs for the past 25 years or more. This investment has contributed to meaningful changes, especially for women and children, who suffer the brunt of the world's disease and disability. Development experts have long debated the relative merits of vertical health programming, targeted to a specific service or patient group, and horizontal programming, supporting more comprehensive care. The U.S. government has invested heavily in vertical programs, most notably through the President's Emergency Plan for AIDS Relief (PEPFAR), its flagship initiative for HIV and AIDS. PEPFAR and programs like it have met with good success. Protecting these successes and continuing progress in the future depends on the judicious integration of vertical programs with local health systems. A strong health system is the best insurance developing countries can have against a disease burden that is shifting rapidly and in ways that history has not prepared us for. Reaching the poor with development assistance is an increasingly complicated task. The majority of the roughly 1 billion people living in dire poverty are in middle-income countries, where foreign assistance is not necessarily needed or welcome. Many of the rest live in fragile states, where political volatility and weak infrastructure make it difficult to use aid effectively. The poorest people in the world are also the sickest; they are most exposed to disease vectors and infection. Nevertheless, they are less likely to access health services. Improving their lot means removing the systemic barriers that keep the most vulnerable people from gaining such access. Investing in Global Health Systems discusses the past and future of global health. First, the report gives context by laying out broad trends in global health. Next, it discusses the timeliness of American investment in health systems abroad and explains how functional health systems support health, encourage prosperity, and advance global security. Lastly, it lays out, in broad terms, an effective donor strategy for health, suggesting directions for both the manner and substance of foreign aid given. The challenge of the future of aid programming is to sustain the successes of the past 25 years, while reducing dependence on foreign aid. Investing in Global Health Systems aims to help government decision makers assess the rapidly changing social and economic situation in developing countries and its implications for effective development assistance. This report explains how health systems improvements can lead to better health, reduce poverty, and make donor investment in health sustainable.

At a time when neoliberal and conservative politics are again in the ascendency and social democracy is waning, Australian public policy re-engages with the values and goals of progressive public policy in Australia and the difficulties faced in re-affirming them. It brings together leading authors to explore economic, environmental, social, cultural, political and Indigenous issues. It examines trends and current policy directions and outlines progressive alternatives that challenge and extend current thinking. While focused on Australia, the contributors offer valuable insights for people in other countries committed to social justice and those engaged in the ongoing contest between neoliberalism and social democracy. This is essential reading for policy practitioners, researchers and students as well as those with an interest in the future of public policy.

What if we can have better health outcomes, at a lower cost, now and for the future? Seriously. Health is driven by four factors: clinical (10%), social (20%), genetics (30%), and behavior (40%). And yet, over 80% of our current health spending is on clinical services. The result? A declining life span and the highest cost per capita in the world. None of us working in public health or medicine should be satisfied with that result. We can do better. The global pandemic has ushered in a brand new day - and unprecedented opportunities in medicine and public health: Forced acknowledgment of the interdependence of public health and medicine Higher and more expansive public expectations Funding availability, and Most importantly, the restlessness of those in the health and healthcare professions to make changes to the traditional system to get better results. The opportunity to change the systems of medicine and public health for the better has never been greater. The good news? The pot of money being spent on health and health care is abundant. The bad news? It's not being spent in the right places. The questions we must all ask ourselves right now are: What outcomes are our health dollars currently driving? What outcomes are we satisfied achieving together? How can we achieve greater health equity? Imagine if we systematically joined the care of the individual (medicine) to the care of the community (public health). How could that change health outcomes now and for the future? Both/And: Medicine & Public Health Together illuminates the path to create an ongoing partnership between public health and medicine, and shows the measurable return on investment already being seen in early adopter communities. Dr. Katie Kaney, a health thought leader with 25 years of experience spanning public health, healthcare, and business, shows exactly how we can use this unprecedented time in human history to make changes to our current health systems now that will pay dividends for decades. BUY NOW and become part of the growing movement to integrate public health and medicine for better health outcomes at a lower cost.

The United States is among the wealthiest nations in the world, but it is far from the healthiest. Although life expectancy and survival rates in the United States have improved dramatically over the past century, Americans live shorter lives and experience more injuries and illnesses than people in other high-income countries. The U.S. health disadvantage cannot be attributed solely to the adverse health status of racial or ethnic minorities or poor people: even highly advantaged Americans are in worse health than their counterparts in other, "peer" countries. In light of the new and growing evidence about the U.S. health disadvantage, the National Institutes of Health asked the National Research Council (NRC) and the Institute of Medicine (IOM) to convene a panel of experts to study the issue. The Panel on Understanding Cross-National Health Differences Among High-Income Countries examined whether the U.S. health disadvantage exists across the life span, considered potential explanations, and assessed the larger implications of the findings. U.S. Health in International Perspective presents detailed evidence on the issue, explores the possible explanations for the shorter and less healthy lives of Americans than those of people in comparable countries, and recommends actions by both government and nongovernment agencies and organizations to address the U.S. health disadvantage.

In 2015, building on the advances of the Millennium Development Goals, the United Nations adopted Sustainable Development Goals that include an explicit commitment to achieve universal health coverage by 2030. However, enormous gaps remain between what is achievable in human health and where global health stands today, and progress has been both incomplete and unevenly distributed. In order to meet this goal, a deliberate and comprehensive effort is needed to improve the quality of health care services globally. Crossing the Global Quality Chasm: Improving Health Care Worldwide focuses on one particular shortfall in health care affecting global populations: defects in the quality of care. This study reviews the available evidence on the quality of care worldwide and makes recommendations to improve health care quality globally while expanding access to preventive and therapeutic services, with a focus in low-resource areas. Crossing the Global Quality Chasm emphasizes the organization and delivery of safe and effective care at the patient/provider interface. This study explores issues of access to services and commodities, effectiveness, safety, efficiency, and equity. Focusing on front line service delivery that can directly impact health outcomes for individuals and populations, this book will be an essential guide for key stakeholders, governments, donors, health systems, and others involved in health care.

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.